Indication
Cutaneous anthrax
Cutaneous anthrax is an acute, localized zoonotic infection of the integumentary system caused by the spore-forming, Gram-positive bacterium *Bacillus anthracis*. Read more about Cutaneous anthrax
147 drugs 89 manufacturers
Drugs that treat it
Common Cutaneous anthrax therapies.
BENZODOX 30 (doxycycline monohydrate/benzoyl peroxide)
DOXYCYCLINE HYCLATE
DOXYCYCLINE MONOHYDRATE
DORYX (doxycycline hyclate)
DOXYCYCLINE HYCLATE
DOXYCYCLINE MONOHYDRATE
DOXYCYCLINE HYCLATE
PENICILLIN G POTASSIUM
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCutaneous anthrax is an acute, localized zoonotic infection of the integumentary system caused by the spore-forming, Gram-positive bacterium *Bacillus anthracis*.
It typically develops in agricultural or industrial workers following direct cutaneous exposure to infected animals, contaminated animal byproducts, or aerosolized spores entering through broken skin.
The condition classically manifests as a pruritic papule that rapidly progresses to a vesicle or ring of hemorrhagic vesicles, culminating in a characteristic painless, depressed ulcer covered by a black necrotic eschar with pronounced surrounding non-pitting edema.
Driven by lethal and edema toxins released during bacterial germination, cutaneous anthrax may remain localized or, if left untreated, disseminate hematogenously, resulting in systemic illness, bacteremia, and substantial morbidity.
- nih.gov
Cutaneous anthrax is an acute, localized zoonotic infection of the integumentary system caused by the spore-forming, Gram-positive bacterium *Bacillus anthracis*
- nih.gov
Cutaneous anthrax is an acute, localized zoonotic infection of the integumentary system caused by the spore-forming, Gram-positive bacterium *Bacillus anthracis* The condition classically manifests as a pruritic papule that rapidly progresses to a vesicle or ring of hemorrhagic vesicles, culminating in a characteristic painless, depressed ulcer covered by a black necrotic eschar with pronounced surrounding non-pitting edema
- cdc.gov
It typically develops in agricultural or industrial workers following direct cutaneous exposure to infected animals, contaminated animal byproducts, or aerosolized spores entering through broken skin Driven by lethal and edema toxins released during bacterial germination, cutaneous anthrax may remain localized or, if left untreated, disseminate hematogenously, resulting in systemic illness, bacteremia, and substantial morbidity
- medlineplus.gov
It typically develops in agricultural or industrial workers following direct cutaneous exposure to infected animals, contaminated animal byproducts, or aerosolized spores entering through broken skin Driven by lethal and edema toxins released during bacterial germination, cutaneous anthrax may remain localized or, if left untreated, disseminate hematogenously, resulting in systemic illness, bacteremia, and substantial morbidity
- nih.gov
The condition classically manifests as a pruritic papule that rapidly progresses to a vesicle or ring of hemorrhagic vesicles, culminating in a characteristic painless, depressed ulcer covered by a black necrotic eschar with pronounced surrounding non-pitting edema
- mayoclinic.org
The condition classically manifests as a pruritic papule that rapidly progresses to a vesicle or ring of hemorrhagic vesicles, culminating in a characteristic painless, depressed ulcer covered by a black necrotic eschar with pronounced surrounding non-pitting edema
Personalize your experience
Follow Cutaneous anthrax and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.